Skip to main
INSP

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 17 analyst ratings
Hold
Strong Buy 12%
Buy 29%
Hold 59%
Sell 0%
Strong Sell 0%

Bulls say

Inspire Medical Systems is experiencing short-term challenges with coding uncertainty and prior authorization delays, leading to lower guidance for revenue and EPS in 2026. However, the company is expected to return to revenue growth in 2027 and its long-term potential is supported by a new product cycle and underpenetrated TAM. Due to the current uncertainties and lack of visibility, we have a neutral rating on the stock.

Bears say

Inspire Medical Systems is facing significant headwinds in the near future due to uncertainty surrounding reimbursement coding and the WISeR program. This has led to a decrease in revenue growth guidance and a decline in the company's stock price. Additionally, the launch of the next-gen Inspire V device may not be enough to offset these challenges and return the company to positive growth in the near term. Investors should monitor the company's progress in addressing these issues before making any investment decisions.

INSP has been analyzed by 17 analysts, with a consensus rating of Hold. 12% of analysts recommend a Strong Buy, 29% recommend Buy, 59% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Hold based on their latest research and market trends.

According to 17 analysts, INSP has a Hold consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92.41, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92.41, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.